Theoretical Studies Applied to the Evaluation of the DFPase Bioremediation Potential Against Chemical Warfare Agents Intoxication
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Organophosphorus compounds (OP) are part of a group of compounds that may be hazardous to health. They are called neurotoxic agents because of their action on the nervous system, inhibiting the acetylcholinesterase (AChE) enzyme and resulting in a cholinergic crisis. Their high toxicity and rapid action lead to irreversible damage to the nervous system, drawing attention to developing new treatment methods. The diisopropyl fluorophosphatase (DFPase) enzyme has been considered as a potent biocatalyst for the hydrolysis of toxic OP and has potential for bioremediation of this kind of intoxication. In order to investigate the degradation process of the nerve agents Tabun, Cyclosarin and Soman through the wild-type DFPase, and taking into account their stereochemistry, theoretical studies were carried out. The intermolecular interaction energy and other parameters obtained from the molecular docking calculations were used to construct a data matrix, which were posteriorly treated by statistical analyzes of chemometrics, using the PCA (Principal Components Analysis) multivariate analysis. The analyzed parameters seem to be quite important for the reaction mechanisms simulation (QM/MM). Our findings showed that the wild-type DFPase enzyme is stereoselective in hydrolysis, showing promising results for the catalytic degradation of the neurotoxic agents under study, with the degradation mechanism performed through two proposed pathways.
Trends in the Recent Patent Literature on Cholinesterase Reactivators (2016-2019).
de Castro A, Assis L, Soares F, Kuca K, Polisel D, da Cunha E Biomolecules. 2020; 10(3).
PMID: 32178264 PMC: 7175240. DOI: 10.3390/biom10030436.
Teixeira J, de Castro A, Soares F, da Cunha E, Ramalho T Molecules. 2019; 24(23).
PMID: 31816853 PMC: 6930470. DOI: 10.3390/molecules24234410.
Enzymatic Bioremediation of Organophosphate Compounds-Progress and Remaining Challenges.
Thakur M, Medintz I, Walper S Front Bioeng Biotechnol. 2019; 7:289.
PMID: 31781549 PMC: 6856225. DOI: 10.3389/fbioe.2019.00289.
Galdino A, Viganor L, de Castro A, da Cunha E, Mello T, Mattos L Front Microbiol. 2019; 10:1701.
PMID: 31428062 PMC: 6688126. DOI: 10.3389/fmicb.2019.01701.
Kandeel M, Kitade Y, Al-Taher A, Al-Nazawi M PLoS One. 2019; 14(2):e0212065.
PMID: 30730992 PMC: 6366710. DOI: 10.1371/journal.pone.0212065.